Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$596K Sell
15,703
-1,497
-9% -$63.1K 0.04% 586
2015
Q2
$683K Sell
17,200
-7,548
-30% -$235K 0.04% 572
2015
Q1
$663K Buy
24,748
+3,459
+16% +$97.6K 0.04% 586
2014
Q4
$625K Sell
21,289
-6,013
-22% -$148K 0.04% 567
2014
Q3
$551K Sell
27,302
-15,100
-36% -$291K 0.04% 573
2014
Q2
$710K Buy
42,402
+4,644
+12% +$65.8K 0.05% 453
2014
Q1
$562K Buy
37,758
+2,215
+6% +$34.1K 0.04% 522
2013
Q4
$520K Buy
35,543
+8,781
+33% +$141K 0.04% 526
2013
Q3
$461K Sell
26,762
-2,390
-8% -$35.5K 0.04% 488
2013
Q2
$338K Buy
+29,152
New +$334K 0.04% 574

Other funds holding AMED

OFI Advisors's AMED Position: Q3 2015 in Review

OFI Advisors reduced its Amedisys (AMED) stake by 8.7% in Q3 2015, selling an estimated $63.1K and leaving 15,703 shares worth $596K. The position accounts for 0.04% of the portfolio, ranked #586.

OFI Advisors first reported a position in AMED in Q2 2013 and has held it in 10 quarters since. The position peaked at $710K in Q2 2014. 173 funds tracked by Wall St. Rank hold AMED as of Q3 2015.

  • OFI Advisors held 15,703 shares of Amedisys worth $596K as of Q3 2015.
  • OFI Advisors sold 1,497 Amedisys shares in Q3 2015, an estimated $63.1K.
  • Amedisys made up 0.04% of OFI Advisors's portfolio in Q3 2015, its #586 holding.
  • OFI Advisors first reported a position in Amedisys in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Amedisys position peaked at $710K in Q2 2014.
  • 173 funds tracked by Wall St. Rank held Amedisys as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.